Jennifer Cather, MD Jennifer Cather, MD Faculty Dr. Jennifer Cather leads Mindful Dermatology. She is a board-certified dermatologist, an active member of the American Academy of Dermatology and is an internationally recognized authority in complex medical dermatology, aesthetics, and skin cancer. Dr. Cather is passionate about diagnosing and managing patient conditions, from the most severe diseases, such as psoriasis or atopic dermatitis, to common skin conditions. Whether seeking the latest medical or rejuvenation advancements in dermatological care, Dr. Cather and her team at Mindful Dermatology are fully invested in our patients. They are constantly raising the standard for dermatology care by providing innovative, research-based therapies and actively seeking new treatments through clinical research. Dr. Cather, a Southern California native, and her husband, Chris, have two daughters, Wonder and Magic. Outside of work, Dr. Cather enjoys staying active and living a healthy lifestyle, whether it's snow skiing, snorkeling, hiking, or stargazing with her husband. PS Winter Home

Lawrence Eichenfield, MD < Back Lawrence Eichenfield, MD Faculty Dr. Eichenfield is chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego and professor of dermatology and pediatrics and vice-chair of the department of dermatology at UC San Diego School of Medicine. He is board certified in dermatology, pediatric dermatology and pediatrics. After earning his medical degree from Mount Sinai School of Medicine in New York, Dr. Eichenfield was a pediatric resident and chief resident at Children's Hospital of Philadelphia. He then completed his dermatology residency at the Hospital of the University of Pennsylvania. Along with longstanding expertise in atopic dermatitis, acne, psoriasis and other inflammatory skin conditions, Dr. Eichenfield has interests in neonatal dermatology, vascular lesions, laser surgery and rare skin disorders. He has authored more than 400 journal articles, chapters, abstracts and books, and has served as the senior editor of "Neonatal and Infant Dermatology," published by Elsevier, as well as "The Eczemas." He served as editor-in-chief of Pediatric Dermatology for 12 years and currently serves on the editorial boards of multiple journals and periodicals. Dr. Eichenfield has held multiple leadership positions, including co-founder and co-chair of the Pediatric Dermatology Research Alliance, co-chair of the American Academy of Dermatology Guidelines for Atopic Dermatitis, co-chair of the American Acne and Rosacea Society/American Academy of Pediatrics Pediatric Acne Recommendations for Diagnosis and Treatment, member of the Expert Panel Member of the NIAID Guidelines for Diagnosis and Management of Food Allergy, Scientific Advisory Board of the National Eczema Association, and director of the Rady Children's/UC San Diego Eczema and Inflammatory Skin Disease Center. Additionally, he has served in leadership roles on guidelines and consensus statements for multiple dermatological conditions, including acne, rosacea, atopic dermatitis and psoriasis. Dr. Eichenfield enjoys running, reading, and skiing. PS Home

Antoanella Calame, MD Antoanella Calame, MD Faculty Dr. Antoanella Calame received her MD degree from University of California, San Diego (UCSD) after graduating Summa Cum Laude from California Lutheran University. She completed her residency in Dermatology at UCSD, followed by a Dermatopathology Fellowship at University of Texas, Southwestern (UTSW) in Dallas, Texas, where she trained with Dr. Clay Cockerell, one of the world leaders in the field of Dermatopathology. Dr. Calame is board certified in Dermatology and Dermatopathology and holds over thirty active state licenses. She is the author of a book on Cutaneous Manifestations of HIV disease and has published numerous peer reviewed scientific papers. Dr. Calame is an invited speaker at local and national conferences every year. She has a special interest in melanoma and melanocytic lesions and is actively involved with the newest clinical and molecular techniques used in the diagnosis and prognosis of cutaneous melanoma. Dr. Calame is the founder and director of Compass Dermatopathology, Poway Dermatology, and the Dermatology Center of La Jolla. She practices Dermatopathology full time and spends a limited time seeing Dermatology patients. Dr. Calame teaches Dermatology and Dermatopathology to the UCSD and Navy Dermatology residents, as well as Dermatology and Pathology residents who come to rotate with her from all over the United States and the world. She has received the annual Excellence in Teaching Award from UTSW and UCSD four times. Dr. Calame’s interests outside of work include tennis, yoga, camping, and spending time with her family. PS Winter Home

Business 201 Faculty < Back Donald Taylor Professor of Practice, Executive Education Director Education MA, Pennsylvania State University, 1988 BS, University of Texas at Arlington, 1979 Professional Organizations Retired US Air Force Colonel, 27 years ACHE, AFA Life Member Board Certified in Healthcare Management, American Academy of Medical Administrators (past) FACHE Certification pending in 2022 Business201 Home

Philip LeBoit, MD < Back Philip LeBoit, MD Faculty Professor of Pathology and Dermatology Division Chief of UCSF Dermatopathology and Oral Pathology Service After training in Anatomic Pathology at the University of California, San Francisco and in Dermatopathology at both New York University (under the late Bernard Ackerman, M.D.) and at New York Hospital-Cornell Medical Center (with N. Scott McNutt, M.D.), Dr. LeBoit founded the UCSF Dermatopathology and Oral Pathology Service in 1987, with the goal of bringing academic expertise to a larger patient base than that of traditional university-based dermatopathology sections. Dr. LeBoit's investigative work includes the delineation of granulomatous slack skin as a lymphoma, the first comprehensive description of bacillary angiomatosis and bacillary peliosis hepatis, the development of the concept of palisaded neutrophilic and granulomatous dermatitis, the application of first morphometric and then molecular studies to melanocytic neoplasms and the initial description of nephrogenic systemic fibrosis. Dr. LeBoit has written over 250 peer reviewed publications, over 25 book chapters, and co-edited the dermatology textbook, Cutaneous Medicine and Surgery. Another major project for the World Health Organization was editing the WHO "blue book" Skin Tumors. Dr. Massi and Dr. LeBoit authored the textbook, Histologic Diagnosis of Nevi and Melanoma, the second edition of which was published in 2014. Dr. LeBoit has given over 400 invited lectures in North and South America, Europe and Asia. Dr. LeBoit served as editor-in-chief of the American Journal of Dermatopathology from 1997-2006, served as an associate editor of the Journal of Investigative Dermatology, and am currently an editor of Seminars in Cutaneous Medicine and Surgery. Dr. LeBoit's service to the International Society of Dermatopathology includes membership on the executive committee and terms as Secretary-Treasurer and as President of the Society (2004-7). Dr. LeBoit have received the Ackerman Award from the International Society of Dermatopathology, and am the only person who has received both the Founders Award and the Pinkus Award from the American Society of Dermatopathology. PS Home

William Posten, MD William Posten, MD Faculty Dr. William Posten is a board-certified, fellowship trained Mohs Surgeon practicing in Dallas, Texas. He received his bachelor’s degree with honors from Harvard University and his M.D. degree from Yale University. He did his dermatology residency training at Northwestern University. He then completed a combined fellowship in Mohs Surgery and Procedural Dermatology at University of Texas Southwestern. Dr. Posten currently serves as President of the Dallas Ft Worth Dermatological Society. He previously served as Secretary-Treasurer of this prestigious organization. He is a Diplomate of the American Board of Dermatology, a Fellow of both the American College of Mohs Surgery and the American Academy of Dermatology, and a member of the American Society of Dermatological Surgery. Dr. Posten authors original research on novel surgical techniques and his findings are regularly presented in national surgical meetings. Recently, Dr. Posten has been featured on Top Docs of DFW, a television program highlighting the leading physicians of Dallas Ft-Worth show on channel 33 KDAF-TV. Dr. Posten is on medical staff at Medical Cities Hospital of Dallas, Presbyterian Hospital of Dallas, Baylor Hospital of Irving, and Zale Lipshy Hospital of Dallas. He teaches medical students and residents surgical skills at UT Southwestern Hospital, Parkland Hospital and the Dallas Veterans Affairs Hospital. Dr. Posten specializes in the treatment of skin cancers and other skin tumors. Dr. Posten believes in a compassionate, caring philosophy that is reflected in the clinical care that he provides. His hobbies include painting and sculpture. He is married with 2 children. He looks forward to meeting you at the Dallas, Las Colinas, and Highland Village offices. PS Winter Home

Business 201 Faculty < Back Chris LeLash Sales Associate Christian LeLash teams with wife, Jennifer, to provide professional luxury real estate services to busy professionals. Together, the LeLash Group has sold millions in luxury properties with sales as high as $12 million. Chris and Jennifer have extensive knowledge of Dallas' real estate market, its private and public schools, and its neighborhoods. They specialize in handling discreet, private real estate transactions for high-net-worth families. Clients attest to Chris’ and Jennifer's professional, discreet, and seamless client service from beginning to end. In addition to real estate, Chris has twenty years of experience in consulting, financial analysis, business development, investments, and high-net-worth client service. He is also a private foundation trustee with experience in investment management, grantmaking, and board governance. Chris attended the University of Pennsylvania and The Wharton School as an undergrad and earned an MBA from New York University's Stern School of Business. Chris enjoys traveling with his family and coaching youth soccer and basketball. Chris and Jennifer are active members within the Shelton and Parish Episcopal school communities and volunteer their time to many charitable efforts close to their hearts. • D Magazine Top Producer 2016-2019 • Multi-Million Dollar Producer • Current or former Board Member, Lymphoma Leukemia Society, Turtle Creek Conservancy, and Wipe Out Kids’ Cancer. https://www.sothebysrealty.com/eng Business201 Home

The COVID-19 pandemic has transformed the business environment for good.Top PR Strategies < Back Top PR Strategies Angela Kambarian | Dermatology Authority Feb 1, 2022 The COVID-19 pandemic has transformed the business environment for good. Now that we are coming off one of the most disruptive years in history, we should probably come to terms with the fact that we might be operating in a business environment that has been transformed for good. Influenced by the prolonged pandemic and rapid technological advancements, we will be a wide variety of new strategies emerging in business to business (B2B) and business to consumer (B2C) marketing. Here are a few to keep in mind as we transition to 2022. Media Outlets Are Relying More on Contributed Articles Since 2008, newsroom employment in the U.S. has fallen 26%, and demand for online content has grown exponentially. It means that media outlets have fewer full-time writers, resulting in increased demand for contributed articles by outside authors – the kind of thought leadership that is highly effective with B2B buyers. By the way, if you have been struggling to convince your executive team to invest the time and effort required for strong thought leadership, 2022 should be your year to change this. PR Professionals Will Use a Variety of Channels to Identify Media Opportunities From Muck Rack and Help a Reporter (HARO) to Twitter and Slack channels, it is easier for PR pros to respond and pitch via a plethora of new emerging platforms and channels. And that’s what digital transformation is all about. Public Relations Campaign Needs a Purpose In 2020 many brands were being heavily scrutinized or criticized for outdated policies, a lack of diversity in the workplace, or reluctance to get involved in social issues and make a difference. In 2021, however, many organizations had finally upgraded their policies, revamped or re-introduced DEI programs, openly expressed outrage over social injustices, and promised to step up their game. In 2022 brands should highlight their mission-based efforts across different communication channels and demonstrate more accountability. Public relation (PR) efforts should be focused on philanthropic involvement and social awareness; it’s crucial that businesses start transitioning from “talking the talk” to “walking the walk” and following through on “do-better” initiatives. Podcast Appearances Should No Longer Be Swept Under the Rug While local and national radio is still best for breaking news, podcasts seem more appropriate for extended discussions of hot topics. These podcasts may not have a vast number of listeners; however, those who do tune in will be highly engaged. If you were putting your appearance on a podcast on the back burner, it is time to give it some serious consideration. Impactful PR Will Have to be Part of a Larger Marketing Ecosystem PR usually generates more traction when combined with other marketing strategies. Let me assure you that in 2022 this will be vital. PR is a piece of the marketing puzzle and needs to be combined with a strong content strategy, paid ads strategy, and social strategy for bigger, better, and more powerful results. Keep it Simple We are living in turbulent and unpredictable times. Sadly, attention spans are short, and anxiety levels are sky-high these days. But the most crucial and impactful form of communication is also the most overlooked. Therefore, in my professional opinion, simplifying a brand message will be one of the important trends in PR for 2022. Companies of all sizes should make sure they avoid fancy language, long-winded copy, and tedious or complicated explanations. Keep your story short. Make it concise, easy-to-understand, and void of “highfalutin” terms. Just explain briefly what it is you do, why it matters, and how your prospects will benefit. ABOUT AUTHOR Angela Kambarian Kambarian.com | 516-724-4372 ABOUT CLAY J. COCKERELL, MD, JD, MBA Dr. Clay J. Cockerell is a world-renowned specialist in treating and diagnosing skin disorders and has diagnosed over three million biopsies. An internationally recognized pioneer in his field and double board-certified in dermatology and dermatopathology, Dr. Cockerell has been practicing medicine since 1986. He is currently the Founder & President of Cockerell Dermatopathology and the Program Director of the Health Education Services dermatology residency program sponsored by the Lake Granbury Medical Center. Also, Dr. Cockerell sees patients a few days per month to assist with resident training and to keep his clinicopathological skills sharp. Dr. Cockerell has held numerous leadership positions within several highly regarded medical associations. Most notably, he served as the President, Secretary & Treasurer and a member of the Board of Directors of the American Academy of Dermatology, President of the Texas Dermatological Society, and President of the Dallas Dermatological Society. Also, Dr. Cockerell holds leadership roles as Founder and President of Cockerell Dermatopathology and a former AmeriPath Board of Directors member. Dr. Cockerell and his wife, Brenda, had a lifelong dream of producing wine and, in 2005, purchased a vineyard in Calistoga, California. They now produce wine under the Coquerel Family Wine Estates label. Dr. Cockerel and Brenda have two children, Charles and Lillian, and they have been married for forty-six years. In addition, Dr. Cockerell and Brenda enjoy traveling, golf, and winter sports. ABOUT COCKERELL DERMATOPATHOLOGY The Cockerell Dermatopathology story begins with Dr. Clay J. Cockerell's vision to establish a practice whose mission is to treat each specimen as if it came from one of own family members. Family! At Cockerell Dermatopathology, every employee is driven by a relentless pursuit of diagnostic excellence. We specialize in evaluating dermatologic disorders, tackling cases ranging from the routine to the most challenging. Our practice continuously invests in cutting-edge technologies to best serve each referring clinician and their patients. These innovations result in higher-quality diagnostic slides, quicker turnaround times for routine cases, and seamless deployment of EMR interfaces. From an educational perspective, Cockerell Dermatopathology is more than a dermatopathology practice. We host numerous in-person and internet-based education events and boast a state-of-the-art 14-headed microscope for dermatology resident training sessions. Our services extend beyond borders, serving hundreds of clinicians in Texas, throughout the United States, and globally. With a highly accessible team of board-certified dermatopathologists and a dedicated support staff, our vision is simple yet profound. Family, we treat every specimen as if it were from one of our own family members. Previous Next

Kim Campbell < Back Kim Campbell Educational Consultant Kim Campbell is the Founder of Dermatology Authority and ClubDerm.com . She has established a medical communications agency focused on collaborations with key opinion leaders, publications, leading societies, and industry partners within the dermatology market. Kim holds a Master's degree in Health Education and Administration, bringing a blend of expertise in healthcare and education to the agency. Dermatology Authority has become a trusted resource delivering high-quality educational programs and partnerships that benefit the dermatology profession. DOD Home

Business 201 Faculty < Back Mark Noble Founder In everything I do, I believe in the "Enrichment of Others!" It is core to who I am and what I offer the world. I train executives and their teams to reduce friction, increase productivity and accelerate company performance across the enterprise. The tools I install in the business enhance collaboration, improve communication and create accountability. My clients range from Stantec Engineering to Alaska Airlines. Industries where I have trained Market Force include mortgage banking, life insurance, architecture, real estate development, construction, commercial property management and logistics. In short, Market Force is industry agnostic. It fits anywhere human beings are charged with coordinating action together. With 25 years of hands-on experience leading commercial real estate brokerage firms, I have spent a majority of my career focused on sales productivity and coaching brokerage teams. I know what it takes to get individuals and teams performing at their very best. Central to my training is the Market Force Technology. Market Force is Human Performance Technology that gets leadership, teams and individual producers performing at ridiculously high levels. It is based on cutting-edge neuroscience and has been trained and taught to over 12,000 professionals in 38 countries. https://www.thenobleforce.com/ Business201 Home

Clay Cockerell, MD, MBA, JD < Back Clay Cockerell, MD, MBA, JD Educational Managing Director Cockerell Dermatopathology , Founder & President Health Education Services sponsored by Lake Granbury Medical Center, Program Director, Residency Program Dermpath On Demand , Co-Founder & Educational Director Dr. Clay J. Cockerell is a world-renowned specialist in treating and diagnosing skin disorders and has diagnosed over three million biopsies. An internationally recognized pioneer in his field and double board-certified in dermatology and dermatopathology, Dr. Cockerell has been practicing medicine since 1986. He is currently the Founder & President of Cockerell Dermatopathology and the Program Director of the Health Education Services dermatology residency program sponsored by the Lake Granbury Medical Center. Also, Dr. Cockerell sees patients a few days per month to assist with resident training and to keep his clinicopathological skills sharp. Dr. Cockerell has held numerous leadership positions within several highly regarded medical associations. Most notably, he served as the President, Secretary & Treasurer and a member of the Board of Directors of the American Academy of Dermatology, President of the Texas Dermatological Society, and President of the Dallas Dermatological Society. Also, Dr. Cockerell holds leadership roles as Founder and President of Cockerell Dermatopathology and a former AmeriPath Board of Directors member. Dr. Cockerell and his wife, Brenda, had a lifelong dream of producing wine and, in 2005, purchased a vineyard in Calistoga, California. They now produce wine under the Coquerel Family Wine Estates label. Dr. Cockerel and Brenda have two children, Charles and Lillian, and they have been married for forty-six years. In addition, Dr. Cockerell and Brenda enjoy traveling, golf, and winter sports. DOD Home

Mark Nestor, MD, PhD < Back Mark Nestor, MD, PhD Faculty Mark S. Nestor, M.D., Ph.D., F.A.A.D. is a board-certified Dermatologist and serves as Director of the Center for Clinical and Cosmetic Research™ and the Center for Cosmetic Enhancement®, Aventura, Florida. He is a Voluntary Professor in the Department of Dermatology and Cutaneous Surgery and the Department of Surgery, Division of Plastic Surgery at the University of Miami, Miller School of Medicine. He is the current President of the American Cutaneous Oncology Society, a past President of the American Society for Photodynamic Therapy, the International Society for Cosmetic and Laser Surgeons, and the Florida Society of Dermatology and Dermatologic Surgery. As Director for CCCR, he has conducted more than 150 FDA and non-FDA clinical trials. Dr. Nestor is recognized as a world expert in clinical therapeutics, drug delivery systems, and research in many areas of clinical Dermatology and aesthetics including acne, psoriasis, and skin cancer, light therapies to treat skin disease, cutaneous laser surgery, photodynamic therapy, and Superficial Radiation Therapy. His aesthetic expertise includes lasers, RF, and other devices, fillers and he recently developed new clinical postulates for botulinum toxins. He has authored over 100 articles and book chapters, has delivered over 1000 major presentations around the world, and is viewed as an internationally acclaimed lecturer and instructor of clinical and aesthetic dermatology. Dr. Nestor also serves as a consultant to numerous pharmaceutical and device companies assisting them in the development of new medications, devices, and cosmeceuticals. He received his MD and PhD in Immunopathology from UCLA School of Medicine and completed his Dermatology Residency at NYU. PS Home